NMUNOENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE VANCOMICINA EN SUERO Y PLASMA HUMANO
Mexico·Clase I·III. Agentes de
diagnóstico·SIEMENS HEALTHCARE
DIAGNOSTICS, S. DE R.L. DE
C.V.·Registered April 22, 2024- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ATELLICA® CH VANCOMICINA (VANC)
- Trade Name (English)
- ATELLICA® CH VANCOMICINA (VANC)
- Analysis ID
- 1148R2024 SSA
- Registration Date
- April 22, 2024
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
Access comprehensive regulatory information for NMUNOENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE VANCOMICINA EN SUERO Y PLASMA HUMANO (NMUNOENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE VANCOMICINA EN SUERO Y PLASMA HUMANO) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1148R2024 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on April 22, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.